Gravity Analytica

Milestone Pharmaceuticals to Present at the Piper Sandler 36th Annual Healthcare Conference

MIST 11.25.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-12-04

Name of Upcoming Event:Piper Sandler 36th Annual Healthcare Conference

Full Press Release SEC Filings Our MIST Tweets

About Gravity Analytica

Recent Filings

PDF Version

MONTREALandCHARLOTTE, N.C.,Nov. 25, 2024(GLOBE NEWSWIRE) --Milestone Pharmaceuticals Inc.(Nasdaq: MIST) today announced that President and CEO,Joe Oliveto, and Chief Commercial Officer,Lorenz Muller, will participate in a fireside chat at the Piper Sandler 36^thAnnual Healthcare Conference onDecember 4, 2024, at 10:30 a.m. Eastern Time.

A live webcast of the fireside chat will be available to conference participants. If you are interested in viewing the fireside chat or meeting with the Milestone team during the conference, emailcorporateaccess@psc.com.

AboutMilestone Pharmaceuticals

Milestone Pharmaceuticals Inc.(Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular solutions to improve the lives of people living with complex and life-altering heart conditions. The Company’s focus on understanding unmet patient needs and improving the patient experience has led us to develop new treatment approaches that provide patients with an active role in self-managing their care. Milestone's lead investigational product is etripamil, a novel calcium channel blocker nasal spray that is being studied for patients to self-administer without medical supervision to treat episodic attacks associated with PSVT and AFib-RVR.

Contact:Kim Fox,Vice President, Communications,kfox@milestonepharma.com

Investor RelationsChris Calabrese,ccalabrese@lifesciadvisors.com

Kevin Gardner,kgardner@lifesciadvisors.com

Source: Milestone Pharmaceuticals Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com